2021

1. Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP)

   International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 694-702